BCB Bancorp Inc. (BCBP) - Q2 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2025. BCB Bancorp, Inc. is a New Jersey-based bank holding company operating BCB Community Bank, which serves New Jersey and New York through 27 locations. The Company operates as a single reportable segment, focusing on commercial, residential, and consumer lending, as well as deposit gathering.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | YTD 2025 (6 Months) | Q2 2024 (3 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Net Income (Loss) | $3.6 million | ($4.8 million) | $2.8 million | $8.7 million |
| Net Income Available to Common | $3.1 million | ($5.7 million) | $2.4 million | $7.8 million |
| Diluted EPS | $0.18 | ($0.33) | $0.14 | $0.46 |
| Net Interest Income | $23.1 million | $45.1 million | $23.6 million | $46.8 million |
| Net Interest Margin (NIM) | 2.80% | 2.70% | 2.60% | 2.55% |
| Provision for Credit Losses | $4.9 million | $25.7 million | $2.4 million | $4.5 million |
| Total Assets | $3.38 billion | - | $3.60 billion (Dec 31, 2024) | - |
| Total Loans (Net) | $2.86 billion | - | $3.00 billion (Dec 31, 2024) | - |
| Total Deposits | $2.66 billion | - | $2.75 billion (Dec 31, 2024) | - |
| Cash & Equivalents | $206.9 million | - | $317.3 million (Dec 31, 2024) | - |
| Allowance for Credit Losses | $50.7 million | - | $34.8 million (Dec 31, 2024) | - |
| Non-Accrual Loans | $101.8 million (3.50% of gross) | - | $44.7 million (Dec 31, 2024) | - |
Material Changes vs. Prior Period
- Profitability Reversal: The Company reported a net loss of $4.8 million for the six months ended June 30, 2025, compared to net income of $8.7 million in the same period in 2024. This was primarily driven by a $21.2 million increase in the provision for credit losses.
- Credit Quality Deterioration: Non-accrual loans more than doubled to $101.8 million (3.50% of gross loans) from $44.7 million at year-end 2024. The allowance for credit losses increased by $15.9 million to $50.7 million.
- Balance Sheet Contraction: Total assets decreased by $218.7 million (6.1%) and total loans decreased by $135.8 million (4.5%) compared to December 31, 2024. Cash and cash equivalents dropped by $110.4 million as the Company reduced exposure to wholesale funding.
- Net Interest Income: NII decreased slightly year-over-year due to lower average balances of interest-earning assets, though the Net Interest Margin improved to 2.80% in Q2 2025 from 2.60% in Q2 2024 due to a faster decline in the cost of liabilities.
Outlook, Risks, and Management Commentary
- Credit Provisioning Drivers: Management attributed the significant increase in loan loss provisions to a $13.7 million specific reserve tied to a $34.2 million loan in the cannabis sector and a $3.1 million increase in reserves for the discontinued Business Express Loan portfolio. The cannabis portfolio totaled $103.0 million at quarter-end.
- Goodwill Impairment Test: Following a Q1 2025 net loss and a sustained decline in stock price, management performed an interim goodwill impairment assessment. The analysis concluded that the fair value of the reporting unit exceeded its carrying amount, resulting in no impairment charge.
- Liquidity and Capital: The Company maintains strong liquidity with $206.9 million in cash and significant borrowing capacity ($226.6 million from FHLB and $196.2 million from the Federal Reserve Discount Window). The Bank exceeded all regulatory capital requirements, with a Community Bank Leverage Ratio of 10.40%.
- Risk Factors: Key risks include the impact of higher tariffs, inflation, and interest rates on economic growth; credit risk associated with the cannabis loan portfolio; and potential declines in real estate values affecting collateral.
- Dividends: On July 28, 2025, the Board declared a cash dividend of $0.16 per share on common stock, payable August 25, 2025.
Investor Verification Checklist
- Cannabis Portfolio Exposure: Verify the specific details of the $34.2 million loan requiring a $13.7 million reserve and the overall health of the $103.0 million cannabis loan segment.
- Non-Accrual Trends: Monitor the trajectory of non-accrual loans, which rose sharply to 3.50% of the portfolio, and the adequacy of the allowance coverage ratio.
- Business Express Portfolio: Review the status of the discontinued Business Express Loan portfolio and the $3.1 million reserve increase associated with it.
- Deposit Stability: Assess the impact of the $89.3 million decrease in total deposits and the shift away from brokered deposits on future funding costs.
- Goodwill Valuation: Re-evaluate the assumptions used in the goodwill impairment test given the recent stock price decline and Q1 loss.